Sonelokimab (Anti-IL-17 & IL-17F & Serum Albumin)
Selected Variant
A4006-1mg
Size: 1 mg
Product Specifications
CAS Number
1414386-05-2
Synonyms
IL17MS3086, ALX-0761, M1095
Target
Interleukins
Applications
Immunology & Inflammation
Additionnal Information
Sonelokimab is a humanized trivalent nanobody consisting of monovalent camelid-derived nanobodies that target human interleukin (IL) -17A, IL-17F, and human serum albumin. It exhibits clinical efficacy and dose-dependent modulation of psoriasis-associated genes in patients with plaque-type psoriasis. MW: 40.93 KD.
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Price
Sign In for Pricing
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC471133-100 1x 100 µL
CD74 (CLIP/1133), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNUM2493-50 1x 50 µL
AIF1 / Iba1 (Microglia Marker) (AIF1/2493), 1mg/mL
Sign In for Pricing
View Details 
BNC401788-500 1x 500 µL
B7-H4 (Immuno-Inhibitory Protein) (B7H4/1788), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042058-100 1x 100 µL
HPV-16 (Human Papilloma Virus 16) (HPV16/2058R), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details